Instil Bio
@InstilBio
Followers
271
Following
0
Media
0
Statuses
7
It was an honor and a privilege to represent @InstilBio at the NYC Half Marathon this weekend. An incredible team doing amazing work fighting for a cure for patients. #unTILcanceriscured #NYCHalfMarathon #cancerresearch #TILtherapy
2
2
8
Come see our CEO, Bronson Crouch, participate at the cell therapy panel discussion at the Cowen 42nd Annual Healthcare Conference on Wednesday at 9:10A ET! https://t.co/6JTXYP17IU
ir.instilbio.com
DALLAS, March 02, 2022 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies...
2
0
4
Today, we reported fourth quarter and full-year 2021 financial results and provided a business update. https://t.co/prO9djuX2n
ir.instilbio.com
- Initiated DELTA-1, a Phase 2 trial of ITIL-168 in advanced melanoma with registrational intent - Received orphan drug and fast-track designation from the U.S. FDA for lead pipeline candidate,...
4
0
3
Instil Bio Announces Poster Presentations at the 2021 @sitcancer Annual Meeting https://t.co/eLIyNpXXnE
ir.instilbio.com
DALLAS, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies...
0
0
0
Instil Bio Reports Third Quarter 2021 Financial Results https://t.co/45RVpprPYt
ir.instilbio.com
Patients enrolled and recruitment ongoing in Phase 2 trial of ITIL-168 in melanoma (DELTA-1) Fast Track Designation granted by FDA for ITIL-168 in metastatic melanoma CoStAR mechanism of action data...
2
0
0
Instil Bio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares https://t.co/ofmp2SRW19
ir.instilbio.com
DALLAS, March 23, 2021 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”), a clinical-stage biopharmaceutical company focused on developing an innovative cell therapy pipeline of autologous TIL therap...
1
0
1
Instil Bio Announces Pricing of Upsized Initial Public Offering -
globenewswire.com
DALLAS, March 18, 2021 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”), a clinical-stage biopharmaceutical company focused on developing an innovative...
0
0
3